These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 17716840

  • 1. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF, Hombach J, Bernkop-Schnürch A.
    Int J Pharm; 2008 Feb 04; 348(1-2):54-60. PubMed ID: 17716840
    [Abstract] [Full Text] [Related]

  • 2. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
    Föger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A.
    Biomaterials; 2006 Dec 04; 27(34):5855-60. PubMed ID: 16919723
    [Abstract] [Full Text] [Related]

  • 3. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
    Föger F, Schmitz T, Bernkop-Schnürch A.
    Biomaterials; 2006 Aug 04; 27(23):4250-5. PubMed ID: 16618504
    [Abstract] [Full Text] [Related]

  • 4. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J, Hoyer H, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2008 Jan 04; 33(1):1-8. PubMed ID: 17980561
    [Abstract] [Full Text] [Related]

  • 5. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    J Control Release; 2004 Mar 24; 95(3):547-55. PubMed ID: 15023465
    [Abstract] [Full Text] [Related]

  • 6. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
    Werle M, Hoffer M.
    J Control Release; 2006 Mar 10; 111(1-2):41-6. PubMed ID: 16377016
    [Abstract] [Full Text] [Related]

  • 7. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
    Iqbal J, Hombach J, Matuszczak B, Bernkop-Schnürch A.
    J Control Release; 2010 Oct 01; 147(1):62-9. PubMed ID: 20603165
    [Abstract] [Full Text] [Related]

  • 8. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
    Iqbal J, Shahnaz G, Perera G, Hintzen F, Sarti F, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2012 Jan 01; 80(1):95-102. PubMed ID: 21964316
    [Abstract] [Full Text] [Related]

  • 9. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
    Bernkop-Schnürch A, Guggi D, Pinter Y.
    J Control Release; 2004 Jan 08; 94(1):177-86. PubMed ID: 14684281
    [Abstract] [Full Text] [Related]

  • 10. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    Int J Pharm; 2006 Jan 13; 307(2):270-7. PubMed ID: 16300914
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
    Kotzé AF, Thanou MM, Luebetaen HL, de Boer AG, Verhoef JC, Junginger HE.
    J Pharm Sci; 1999 Feb 13; 88(2):253-7. PubMed ID: 9950647
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
    Fortuna A, Alves G, Falcão A, Soares-da-Silva P.
    Epilepsia; 2012 Mar 13; 53(3):529-38. PubMed ID: 22372629
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR, Sharma CP.
    J Control Release; 2009 Apr 17; 135(2):144-51. PubMed ID: 19331862
    [Abstract] [Full Text] [Related]

  • 14. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
    Cao X, Yu LX, Barbaciru C, Landowski CP, Shin HC, Gibbs S, Miller HA, Amidon GL, Sun D.
    Mol Pharm; 2005 Apr 17; 2(4):329-40. PubMed ID: 16053336
    [Abstract] [Full Text] [Related]

  • 15. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM, Dorkoosh FA, Avadi MR, Weinhold M, Bayat A, Delie F, Gurny R, Larijani B, Rafiee-Tehrani M, Junginger HE.
    Eur J Pharm Biopharm; 2008 Sep 17; 70(1):270-8. PubMed ID: 18492606
    [Abstract] [Full Text] [Related]

  • 16. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
    Okudaira N, Komiya I, Sugiyama Y.
    J Pharmacol Exp Ther; 2000 Nov 17; 295(2):717-23. PubMed ID: 11046110
    [Abstract] [Full Text] [Related]

  • 17. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
    Sha X, Fang X.
    Int J Pharm; 2004 Mar 19; 272(1-2):161-71. PubMed ID: 15019079
    [Abstract] [Full Text] [Related]

  • 18. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
    Thomsen AE, Christensen MS, Bagger MA, Steffansen B.
    Eur J Pharm Sci; 2004 Dec 19; 23(4-5):319-25. PubMed ID: 15567284
    [Abstract] [Full Text] [Related]

  • 19. Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan.
    Föger F, Kafedjiiski K, Hoyer H, Loretz B, Bernkop-Schnürch A.
    J Drug Target; 2007 Feb 19; 15(2):132-9. PubMed ID: 17365284
    [Abstract] [Full Text] [Related]

  • 20. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
    Franco M, Lopedota A, Trapani A, Cutrignelli A, Meleleo D, Micelli S, Trapani G.
    Int J Pharm; 2008 Mar 20; 352(1-2):182-8. PubMed ID: 18055143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.